Topic: ALLERGAN
64 results were found.
Settlements totaling $20.1 billion with CVS, Walgreens, Walmart Pharmacies, Teva and Allergan for opioid crisis - January 16, 2023
Illinois announces $6.6 billion settlement with opioid makers Teva and Allergan - November 30, 2022
Illinois AG Raoul announces agreement with former opioid maker Allergan - August 3, 2022
FTC approves final order imposing conditions on AbbVie’s acquisition of Allergan - September 5, 2020
AbbVie completes acquisition of Allergan - May 9, 2020
Clearance from U.S. Federal Trade Commission for AbbVie's acquisition of Allergan - May 6, 2020
Allergan Q4 GAAP operating loss $276.6 million - February 10, 2020
Nestle buys Allergan business to expand in medical nutrition - January 27, 2020
Allergan Q3 GAAP net revenues $4.05 billion - November 6, 2019
Allergan Q1 GAAP operating loss $2.31 billion - May 7, 2019
Almirall closes agreement with Allergan and acquires its U.S. medical dermatology portfolio - September 21, 2018
Allergan to acquire Bonti Adding new neurotoxin programs to medical aesthetics pipeline - September 14, 2018
Almirall to buy 5 dermatology brands from Allergan for $650 million - August 3, 2018
Allergan tried shield patents through tribe deal - July 21, 2018
Allergan backs away from Shire but reserves right to change - April 20, 2018
Allergan net revenue up 12 percent - February 6, 2018
Allergan appoints Matthew M. Walsh as CFO - February 6, 2018
Allergan to eliminate 1,400 positions - January 3, 2018
Pershing Square and Valeant will pay to settle Allergan lawsuit - December 31, 2017
U.S. House committee launches probe of Allergan patent hiding - October 4, 2017
Allergan appoints Joseph Boccuzi to board - July 20, 2017
Allergan Q1 total net revenues $3.6 billion - May 9, 2017
Allergan to buy Zeltiq Aesthetics for $2.48 billion - February 13, 2017
Allergan Q4 adjusted operating income $1.87 billion - February 9, 2017
Allergan adds Adriane Brown to board - February 6, 2017
Allergan paying $15m for disclosure failures during merger talks - January 17, 2017
Allergan to buy Acelity's LifeCell for $2.9 billion - December 20, 2016
Adriane Brown to join Allergan board of directors - November 15, 2016
Allergan Q3 net revenues $3.6 billion - November 3, 2016
Allergan names Brenton Saunders chairman of board of directors - October 27, 2016
Teva completes acquisition of Allergan's Anda - October 4, 2016
Allergan generates $6.35 billion for California - September 27, 2016
Allergan to buy Tobira Therapeutics for $28.35 per share in cash - September 20, 2016
Allergan to buy Vitae Pharma for $639 million - September 14, 2016
Allergan Q2 net revenues $3.7 billion - August 8, 2016
Teva Pharma to buy Allergan's Anda distribution for half a billion - August 3, 2016
Impax Labs to buy generics from Teva and Allergan for $586 million - June 22, 2016
Carl Icahn takes 'large position' in Allergan - May 31, 2016
Allergan net revenue increase 48 percent to $3.8 billion - May 10, 2016
Pfizer steps back from $150 billion takeover of Allergan - April 6, 2016
Teva sees close of $40.5 billion Allergan generics deal by June - March 16, 2016
EU approves acquisition of Allergan Generics by Teva with conditions - March 10, 2016
Allergan net revenue from continuing operations increased 74% - February 23, 2016
Pfizer/Allergan: Brent Saunders president, COO of the combined company - February 10, 2016
Former Allergan chairman and CEO joins BioMarin Pharma board - January 5, 2016
Pfizer and Allergan to merge in $160 billion deal - November 23, 2015
Allergan Q3 net revenue increased 90 percent - November 5, 2015
Pfizer confirms discussions with Allergan - October 29, 2015
Allergan expects revenue to be greater than $8 billion - September 30, 2015
Allergan to buy AqueSys for $300 million plus milestone payments - September 5, 2015
Allergan recalling products over eye injuries fears - August 25, 2015
Allergan completes Oculeve acquisition - August 11, 2015
Allergan and Kythera Biopharmaceuticals amended their merger deal - August 6, 2015
Teva secures $33.75 billion for acquisition of Allergan's generic business - July 31, 2015
Teva withdraws from Mylan, will buy Allergan Generics in $40.5 billion transaction - July 27, 2015
Allergan buys rights to Merck's migraine drugs - July 8, 2015
Allergan to acquire Oculeve for $125m plus milestone payments - July 7, 2015
Allergan to buy Kythera Biopharmaceuticals for $2.1 billion - June 17, 2015
Actavis is now Allergan, trade symbol AGN - June 15, 2015
Actavis names two former Allergan board members to its board - March 18, 2015
European Commission clears Actavis' acquisition of Allergan - March 17, 2015
Actavis to change name to Allergan, selling $8.4bn in shares to finance takeover - February 19, 2015
Allergan names EVP, finance and business development, CFO - August 19, 2014
Allergan appoints Douglas S. Ingram as president - June 25, 2013